Medical device development and innovation for rare and pediatric populations: a global landscape overview
Regulatory pathways modeled after orphan drug programs could unlock medical device innovation for rare and pediatric diseases.
IRDiRC Working Group landscape review identifies significant unmet need and developmental gaps in medical device innovation for rare and pediatric disease populations. Regulatory incentives parallel to orphan drug pathways are proposed as key enablers for the orphan device ecosystem.
What the study was
- Study design
- Narrative landscape review
- Population
- Rare disease and pediatric populations globally
- Category
- Other
- Maturity
- Exploratory
- Journal
- Orphanet Journal of Rare Diseases
Why it surfaced
Landscape overview only; no primary data. Informative policy context for rare disease device development but minimal triage signal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.